DEPOMED INC's ticker is and the CUSIP is 249908AA2. A total of 46 filers reported holding DEPOMED INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $12,787,000 | -27.7% | 15,665,000 | -27.6% | 0.27% | -22.5% |
Q1 2018 | $17,682,000 | +1.6% | 21,651,000 | +5.4% | 0.35% | +4.2% |
Q4 2017 | $17,398,000 | -2.7% | 20,534,000 | -14.8% | 0.33% | -1.8% |
Q3 2017 | $17,887,000 | -27.3% | 24,110,000 | -13.7% | 0.34% | -28.0% |
Q2 2017 | $24,614,000 | +4.9% | 27,933,000 | +12.2% | 0.47% | +7.3% |
Q1 2017 | $23,470,000 | -7.1% | 24,905,000 | +13.3% | 0.44% | -5.6% |
Q4 2016 | $25,252,000 | +41.7% | 21,985,000 | +76.0% | 0.46% | +80.2% |
Q3 2016 | $17,819,000 | -1.8% | 12,488,000 | -17.0% | 0.26% | -8.2% |
Q2 2016 | $18,138,000 | +39.3% | 15,053,000 | +8.3% | 0.28% | +41.2% |
Q1 2016 | $13,020,000 | -27.9% | 13,895,000 | -9.7% | 0.20% | -28.4% |
Q4 2015 | $18,066,000 | +76.0% | 15,395,000 | +79.1% | 0.28% | +77.1% |
Q3 2015 | $10,264,000 | -36.8% | 8,595,000 | -32.0% | 0.16% | -32.9% |
Q2 2015 | $16,251,000 | +138.7% | 12,647,000 | +145.4% | 0.23% | +138.8% |
Q1 2015 | $6,807,000 | -63.1% | 5,153,000 | -69.7% | 0.10% | -63.8% |
Q4 2014 | $18,458,000 | +20.3% | 16,996,000 | +17.2% | 0.27% | +14.3% |
Q3 2014 | $15,343,000 | +1.2% | 14,500,000 | 0.0% | 0.24% | +4.9% |
Q2 2014 | $15,167,000 | – | 14,500,000 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|